A Phase 3b/4 Randomized Double Blind Placebo Controlled Study Of Methotrexate (Mtx) Withdrawal In Subjects With Rheumatoid Arthritis (ra) Treated With Tofacitinib 11mg Modified Release (mr) Formulation
Phase of Trial: Phase III/IV
Latest Information Update: 27 Nov 2017
At a glance
- Drugs Tofacitinib (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Pfizer
- 21 Nov 2017 Planned End Date changed from 20 Mar 2019 to 3 Nov 2018.
- 21 Nov 2017 Planned primary completion date changed from 20 Mar 2019 to 3 Nov 2018.
- 10 Jun 2017 Biomarkers information updated